Assignee
SYNTA PHARMACEUTICALS CORP
US·87 granted patents·69 pending applications·1,682 citations·filing 2001–2019
Top patents by PatentIndex Score
156 records- 0198US8034834B2Method for treating proliferative disorders with HSP90 inhibitorsSYNTA PHARMACEUTICALS CORP·Filed 2007·Granted Oct 11, 2011·53 cites·15 claims
- 0298US7435843B2Synthesis of taxol enhancersSYNTA PHARMACEUTICALS CORP·Filed 2006·Granted Oct 14, 2008·36 cites·4 claims
- 0398US7368473B2Paclitaxel enhancer compoundsSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted May 6, 2008·40 cites·23 claims
- 0497US8053456B2Triazole compounds that modulate Hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2007·Granted Nov 8, 2011·58 cites·12 claims
- 0597US7074952B2Synthesis of taxol enhancersSYNTA PHARMACEUTICALS CORP·Filed 2004·Granted Jul 11, 2006·49 cites·25 claims
- 0697US7001923B2Taxol enhancer compoundsSYNTA PHARMACEUTICALS CORP·Filed 2004·Granted Feb 21, 2006·52 cites·24 claims
- 0797US6825235B2Synthesis of taxol enhancersSYNTA PHARMACEUTICALS CORP·Filed 2002·Granted Nov 30, 2004·60 cites·60 claims
- 0896US7825148B2Triazole compounds that modulate Hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Nov 2, 2010·53 cites·51 claims
- 0996US7750042B2Paclitaxel enhancer compoundSYNTA PHARMACEUTICALS CORP·Filed 2008·Granted Jul 6, 2010·14 cites·32 claims
- 1096US7615552B2Fused heterocyclic compoundsSYNTA PHARMACEUTICALS CORP·Filed 2004·Granted Nov 10, 2009·87 cites·46 claims
- 1196US7345094B2Paclitaxel enhancer compoundsSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Mar 18, 2008·40 cites·31 claims
- 1296US7037940B2Taxol enhancer compoundsSYNTA PHARMACEUTICALS CORP·Filed 2004·Granted May 2, 2006·55 cites·24 claims
- 1396US6924312B2Taxol enhancer compoundsSYNTA PHARMACEUTICALS CORP·Filed 2003·Granted Aug 2, 2005·58 cites·3 claims
- 1496US6800660B2Taxol enhancer compoundsSYNTA PHARMACEUTICALS CORP·Filed 2002·Granted Oct 5, 2004·71 cites·117 claims
- 1595US8835464B2Triazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2013·Granted Sep 16, 2014·32 cites·17 claims
- 1695US8628752B2Methods of identifying HSP90 inhibitors with less ocular toxicitySYNTA PHARMACEUTICALS CORP·Filed 2012·Granted Jan 14, 2014·15 cites·8 claims
- 1795US7645904B2Purification of bis(thiohydrazide amides)SYNTA PHARMACEUTICALS CORP·Filed 2007·Granted Jan 12, 2010·18 cites·29 claims
- 1895US7608635B2Pyrazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2006·Granted Oct 27, 2009·32 cites·11 claims
- 1994US7795313B2Bis(thio-hydrazide amide) salts for treatment of cancersSYNTA PHARMACEUTICALS CORP·Filed 2009·Granted Sep 14, 2010·22 cites·18 claims
- 2094US7709518B2Compounds for inflammation and immune-related usesSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted May 4, 2010·33 cites·19 claims
- 2194US7662813B2Triazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2006·Granted Feb 16, 2010·35 cites·35 claims
- 2294US7579503B2BIS (thio-hydrazide amide) salts for treatment of cancersSYNTA PHARMACEUTICALS CORP·Filed 2008·Granted Aug 25, 2009·23 cites·15 claims
- 2394US6660733B22,4,6-trisubstituted-pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2002·Granted Dec 9, 2003·69 cites·25 claims
- 2493US7919487B2Heteroaryl compoundsSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Apr 5, 2011·34 cites·15 claims
- 2593US7863270B2IL-12 modulatory compoundsSYNTA PHARMACEUTICALS CORP·Filed 2006·Granted Jan 4, 2011·24 cites·4 claims
- 2693US7709683B2Synthesis of bis(thio-hydrazide amide) saltsSYNTA PHARMACEUTICALS CORP·Filed 2006·Granted May 4, 2010·13 cites·25 claims
- 2793US7671092B2Paclitaxel enhancer compoundsSYNTA PHARMACEUTICALS CORP·Filed 2008·Granted Mar 2, 2010·16 cites·5 claims
- 2893US7067514B2Pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2003·Granted Jun 27, 2006·42 cites·46 claims
- 2993US6743919B22-aroylimidazole compounds for treating cancerSYNTA PHARMACEUTICALS CORP·Filed 2002·Granted Jun 1, 2004·30 cites·66 claims
- 3093US6693097B2Pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2001·Granted Feb 17, 2004·60 cites·39 claims
- 3192US7923557B2Process for preparing trisubstituted pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Apr 12, 2011·24 cites·8 claims
- 3292US7816535B2Vinyl-phenyl derivatives for inflammation and immune-related usesSYNTA PHARMACEUTICALS CORP·Filed 2007·Granted Oct 19, 2010·25 cites·10 claims
- 3392US7678832B2Bis(thio-hydrazide amide) formulationSYNTA PHARMACEUTICALS CORP·Filed 2006·Granted Mar 16, 2010·18 cites·16 claims
- 3492US7652168B2Synthesis of taxol enhancersSYNTA PHARMACEUTICALS CORP·Filed 2008·Granted Jan 26, 2010·13 cites·8 claims
- 3591US6958332B2Pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2003·Granted Oct 25, 2005·39 cites·32 claims
- 3690US7781462B2Compounds for the treatment of proliferative disordersSYNTA PHARMACEUTICALS CORP·Filed 2006·Granted Aug 24, 2010·5 cites·23 claims
- 3790US7745436B2Disalt inhibitors of IL-12 productionSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Jun 29, 2010·15 cites·6 claims
- 3890US7470685B2Pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Dec 30, 2008·11 cites·33 claims
- 3990US6680315B2Triazine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2001·Granted Jan 20, 2004·34 cites·46 claims
- 4089US8748424B2Triazole compounds that modulate Hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2012·Granted Jun 10, 2014·12 cites·3 claims
- 4189US7470681B2Pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Dec 30, 2008·12 cites·25 claims
- 4289US7122665B2Heterocyclic compoundsSYNTA PHARMACEUTICALS CORP·Filed 2003·Granted Oct 17, 2006·29 cites·28 claims
- 4389US7045517B2Triazine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2003·Granted May 16, 2006·37 cites·53 claims
- 4488US9597343B2Targeted therapeuticsSYNTA PHARMACEUTICALS CORP·Filed 2014·Granted Mar 21, 2017·4 cites·9 claims
- 4588US9206162B2Triazole compounds that modulate Hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2015·Granted Dec 8, 2015·6 cites·3 claims
- 4688US8937094B2Triazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2013·Granted Jan 20, 2015·9 cites·18 claims
- 4788US7465725B2Pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Dec 16, 2008·8 cites·37 claims
- 4887US9439899B2Cancer therapy using a combination of HSP90 inhibitors with topoisomerase I inhibitorsSYNTA PHARMACEUTICALS CORP·Filed 2012·Granted Sep 13, 2016·7 cites·17 claims
- 4987US9006277B2Triazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2014·Granted Apr 14, 2015·7 cites·8 claims
- 5087US8921407B2Pyrazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2012·Granted Dec 30, 2014·7 cites·15 claims
Showing the top 50 of 156 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when SYNTA PHARMACEUTICALS CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →